Scientists at Orion Genomics and other labs, including Cold Spring Harbor, have used microarrays in a genome-wide screen to look for epigenetic biomarkers for early stage detection of breast cancer. In the study, published yesterday in PLoS ONE, they found about 200 loci that were differentially methylated, and then went on to validate these in 230 clinical samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.